EDA and inflammatory bowel disease: Therefore, our data demonstrate that the administration of miR-494-3p agomir protects mice from DSS-induced colitis and further show that miR-494-3p negatively correlates with IKKβ and EDA-A2/EDA2R in patients with active IBD.